# Evaluation of the Condition of Rheumatoid Arthritis After Treatment

> **NCT02157012** · PHASE4 · UNKNOWN · sponsor: **Shinshu University** · enrollment: 100 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** The effectiveness of Xeljanz in rheumatoid arthritis patients

## Key facts

- **NCT ID:** NCT02157012
- **Lead sponsor:** Shinshu University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2022-04
- **Final completion:** 2025-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02157012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02157012, "Evaluation of the Condition of Rheumatoid Arthritis After Treatment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02157012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*